Sonogenmed
Chevy Chase, US · Founded 2020 · Delaware corporation · 3 known investors
Sonogen Medical develops a portable, home-use device for bone growth stimulation that uses modern science to accelerate fracture healing in patients. The device requires just 20 minutes daily usage and provides real-time feedback on healing progress, targeting the approximately 10% of fracture cases that experience delayed or failed healing.
Digital HealthHealthtechMedical Devices
Founders & leadership
JW
Jason WinderExecutive Officer, Director
RM
Robert MuratoreExecutive Officer
FS
Frank SchugarExecutive Officer
Investors · 3
Competitors · 7
by search overlapDiabetes Prevention Program36 shared keywords
Dervan et al18 shared keywords
Bioventus18 shared keywordsBioventus develops orthobiologics and pain treatment products for orthopedic care, offering therapies such as the StimRouter neurostimulation device for chronic peripheral nerve pain. Its portfolio serves patients, physicians, and payers in the medical device and healing space.
Cleveland Clinic, 202215 shared keywordsCleveland Clinic is a patient-centered academic medical center providing clinical care, research, and medical education. The organization offers services ranging from primary care and virtual visits to specialized treatment, clinical trials, and advanced medical research.
ResearchGate15 shared keywords
Fda11 shared keywords
Healthline10 shared keywordsHealthline publishes medically reviewed health and wellness content for general consumers, drawing on a network of medical reviewers. It operates as a consumer health media and information platform.
Companies competing with Sonogenmed for the same Google search keywords, organic and paid, via search-intersection analysis.
Reported raises · per SEC filings
Form D private placements▶$125KraisedSep 2021 · 3 investors · OtherRule 506(b)
▶$125KraisedSep 2021 · 3 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Jason WinderExecutive Officer, Director
- Robert MuratoreExecutive Officer
- Frank SchugarExecutive Officer
- Offering amount
- $250K
- Amount sold
- $125K
- Minimum investment
- $25K
- First sale
- May 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.